Abstract
The following literature search is in response to inquiries made to the American Society for Metabolic and Bariatric Surgery (ASMBS) regarding antiobesity medication (AOM) use in patients who are having or have already had metabolic and bariatric surgery (MBS). These recommendations are based on current clinical knowledge, expert opinion, and published peer-reviewed scientific evidence available at this time. This paper is not intended to establish a local, regional, or national standard of care. The paper will be revised in the future as additional evidence becomes available.
Original language | English (US) |
---|---|
Pages (from-to) | 1109-1119 |
Number of pages | 11 |
Journal | Surgery for Obesity and Related Diseases |
Volume | 18 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2022 |
Keywords
- Bariatric Surgery/adverse effects
- Humans
- United States
ASJC Scopus subject areas
- Surgery